Literature DB >> 18798258

An activating mutation in AKT1 in human prostate cancer.

Joost L Boormans, Karin G Hermans, Geert J L H van Leenders, Jan Trapman, Paul C M S Verhagen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18798258     DOI： 10.1002/ijc.23787

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  9 in total

Review 1.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

2.  Comprehensive gene expression analysis reveals multiple signal pathways associated with prostate cancer.

Authors:  Yi Liu; Hua Song; Jing Pan; Jing Zhao
Journal:  J Appl Genet       Date:  2013-10-24       Impact factor: 3.240

3.  Mutation frequency in 15 common cancer genes in high-risk head and neck squamous cell carcinoma.

Authors:  Sean M McBride; S Michael Rothenberg; William C Faquin; Annie W Chan; John R Clark; Leif W Ellisen; Lori J Wirth
Journal:  Head Neck       Date:  2014-03-10       Impact factor: 3.147

Review 4.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

Review 5.  Akt inhibitors in clinical development for the treatment of cancer.

Authors:  Sumanta Kumar Pal; Karen Reckamp; Hua Yu; Robert A Figlin
Journal:  Expert Opin Investig Drugs       Date:  2010-09-16       Impact factor: 6.206

6.  Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.

Authors:  Stella Koutros; Fredrick R Schumacher; Richard B Hayes; Jing Ma; Wen-Yi Huang; Demetrius Albanes; Federico Canzian; Stephen J Chanock; E David Crawford; W Ryan Diver; Heather Spencer Feigelson; Edward Giovanucci; Christopher A Haiman; Brian E Henderson; David J Hunter; Rudolf Kaaks; Laurence N Kolonel; Peter Kraft; Loïc Le Marchand; Elio Riboli; Afshan Siddiq; Mier J Stampfer; Daniel O Stram; Gilles Thomas; Ruth C Travis; Michael J Thun; Meredith Yeager; Sonja I Berndt
Journal:  Cancer Res       Date:  2010-03-02       Impact factor: 12.701

7.  E17K substitution in AKT1 in prostate cancer.

Authors:  J L Boormans; H Korsten; A C J Ziel-van der Made; G J L H van Leenders; P C M S Verhagen; J Trapman
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

8.  A potential role for intragenic miRNAs on their hosts' interactome.

Authors:  Ludwig Christian G Hinske; Pedro A F Galante; Winston P Kuo; Lucila Ohno-Machado
Journal:  BMC Genomics       Date:  2010-10-01       Impact factor: 3.969

Review 9.  Calcium and Nuclear Signaling in Prostate Cancer.

Authors:  Ivan V Maly; Wilma A Hofmann
Journal:  Int J Mol Sci       Date:  2018-04-19       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.